Richard Hertzberg serves as Executive at Cellectar Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Richard Hertzberg has executed 13 insider transactions totaling $2.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 31, 2016 involved selling 21,000 shares valued at $42.6K.
Richard Hertzberg currently holds 280,000 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Hertzberg has been a net buyer of CLRB stock. They have purchased $2.4M and sold $42.6K worth of shares.
Richard Hertzberg's most recent insider trade was on Oct 31, 2016, when they sold 21,000 shares at $2.03 per share.
Get notified when new Form 4 filings are submitted
| $1.90 |
| Discretionary |
| Apr 15, 2016 | CLRB | $497.7K | Purchase | 234,742 | $2.12 | Discretionary |
| Dec 28, 2015 | CLRB | $54.0K | Purchase | 75,000 | $0.72 | Discretionary |
| Dec 24, 2015 | CLRB | $39.5K | Purchase | 50,000 | $0.79 | Discretionary |
| Dec 22, 2015 | CLRB | $4.5K | Purchase | 5,000 | $0.91 | Discretionary |
| Dec 16, 2015 | CLRB | $17.8K | Purchase | 19,592 | $0.91 | Discretionary |
| Dec 11, 2015 | CLRB | $14.9K | Purchase | 16,250 | $0.92 | Discretionary |
| Dec 8, 2015 | CLRB | $9.2K | Purchase | 10,000 | $0.92 | Discretionary |
| Oct 3, 2014 | CLRB | $22.5K | Purchase | 10,000 | $2.25 | Discretionary |
| Sep 19, 2014 | CLRB | $53.4K | Purchase | 20,000 | $2.67 | Discretionary |
| Aug 20, 2014 | CLRB | $1.5M | Purchase | 409,158 | $3.75 | Discretionary |
| Dec 5, 2011 | CLRB | $120.0K | Purchase | 10,000 | $12.00 | Discretionary |